Shankar Siva, MBBS, PhD, FRANZCR, discussed when to consider cytoreductive SABR in patients with metastatic kidney cancer responding to systemic therapy.
Press Release|Articles|September 18, 2025
ACRO Issues Comments to CMS on Proposed Rules
Author(s)ACRO
As noted in the letters, "ACRO’s comments seek to ensure ongoing access to high-quality, state-of-the-art radiation oncology services."
Advertisement
ACRO has submitted comments to the Centers for Medicare and Medicaid Services (CMS) on the proposed rule for the CY 2026 Physician Fee Schedule (CMS-1832-P), as well as the CY 2026 Hospital Outpatient Prospective Payment System Proposed Rule (CMS-1834-P).
The first letter (CMS-1832-P) offers comments and recommendations on the following issues:
- Appropriate APC Placement for Treatment Delivery Codes (77402, 77407, 77412)
- Use of OPPS data to set PFS rates
- Updates to the Indirect Practice Expense (PE) Methodology
- Removal of 77427 from the Telehealth List
- Undervaluation of conversion factor due to G2211 Assumption
- Efficiency Adjustment
- Valuation of Imaging Guidance for Proton Beam Treatment Delivery (CPT codes 77520, 77522, 77523, and 77525)
The second letter (CMS-1834-P) offers comments on:
- Appropriate APC Placement for Treatment Delivery Codes (77402, 77407, 77412)
- BgRT
Advertisement
Related to this article
Bhanu Prasad Venkatesulu, MBBS, MD, discussed why fewer radiation oncologists perform brachytherapy, and one setting where he considers it the better option.
Adam C. Olson, MD, MSc-GH, discussed letting patients choose between modalities with comparably strong evidence and the data that shaped his approach.
Adam C. Olson, MD, MSc-GH, discussed the infrastructure, training, and shared decision-making behind building a prostate HDR brachytherapy program.
In HypoMast-IMNI, 16-fraction PMRT with internal mammary node irradiation matched conventional RT for locoregional control with less grade 3 skin toxicity.
Tyler J. Wilhite, MD, discussed coordinating with rheumatology, orthopedic surgery, and primary care when treating patients with osteoarthritis with low-dose radiation therapy.
Tyler J. Wilhite, MD, discussed scaling low-dose radiation therapy for osteoarthritis from 1 patient to nearly 20 centers and the referral work behind it.
Findings may provide reassurance to patients with early-stage disease that surgery may help improve survival rates.
Advertisement
Advertisement
Trending on CancerNetwork
1
Pasritamig Plus JNJ-9401 Yields 73% PSA Response in Metastatic CRPC
2
Nogapendekin Alfa/BCG Earns Israeli Approval in BCG-Unresponsive NMIBC
3
PIKTOR Plus Paclitaxel Yields Responses in Pretreated PAM-Mutated Endometrial Cancer
4
Cesalatamig Monotherapy Yields Responses in PD-(L)1–Resistant NSCLC
5